Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-03

Clinical Trial Update: Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Norgestrel 75 mcg on cervical mucus and ovarian activity under perfect-use, after a delayed intake, and after a missed pi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norgestrel 75 mcg (norgestrel)

Snippet

Sponsor: HRA Pharma | Conditions: Contraception | Phase 2 | Status: COMPLETED | Results posted: 2021-06-03